AsOf

Recorded or changed on this day 2026-11-08

45,051–45,100 of 46,534 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -56,933,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -56,933,000 United States dollar, claim clm_802A10BA2903 · ended · superseded by clm_31AFB2309D37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 22,429,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 22,429,000 United States dollar, claim clm_803A751AACB0 · ended · superseded by clm_91E848597DF5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 139,331,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 139,331,000 United States…, claim clm_807DBFE23E9F · ended · superseded by clm_E5A0F7F2EB85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 2,906,116,000 United States dollar
Vertex Pharmaceuticals total equity: 2,906,116,000 United States dollar, claim clm_815A8BEADE9D · ended · superseded by clm_38ED4A3E086C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 57,518,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 57,518,000 United States dollar, claim clm_81C047352B0D · ended · superseded by clm_98EA8D3ED9D1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,155,905,000 United States dollar
Vertex Pharmaceuticals total equity: 1,155,905,000 United States dollar, claim clm_81C9DAEE5D23 · ended · superseded by clm_16DE270CBEB7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,374,073,000 United States dollar
Vertex Pharmaceuticals total assets: 2,374,073,000 United States dollar, claim clm_82FAC17B63B7 · ended · superseded by clm_60B4E50AFB70 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 6,063,678,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 6,063,678,000 United States dollar, claim clm_84A1E26AC5B8 · ended · superseded by clm_CC12F522D151 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 475,320,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 475,320,000 United States dollar, claim clm_84EBB48920A6 · ended · superseded by clm_B1D95D9229AF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,671,273,000 United States dollar
Vertex Pharmaceuticals total equity: 1,671,273,000 United States dollar, claim clm_8500F4409507 · ended · superseded by clm_2F530EB00B1B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,771,900,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,771,900,000 United States dollar, claim clm_85558B741195 · ended · superseded by clm_1EC0DE7E99A1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 91,649,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 91,649,000 United States dollar, claim clm_85DA72CF3BE5 · ended · superseded by clm_0A5AAF6DC9F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 309,816,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 309,816,000 United States dollar, claim clm_86562BC405C6 · ended · superseded by clm_D1405FE577D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 493,751,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 493,751,000 United States…, claim clm_86D501AB2F5C · ended · superseded by clm_CF81367A05A7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 196,544,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 196,544,000 United States…, claim clm_87BBE0E23F91 · ended · superseded by clm_440DD76F9BF9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 915,700,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 915,700,000 United States dollar, claim clm_87BE0FC8B08C · ended · superseded by clm_78BFE90ACA99 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 413,783,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 413,783,000 United States dollar, claim clm_882D250549DB · ended · superseded by clm_7D8A031A80DB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 13,432,500,000 United States dollar
Vertex Pharmaceuticals total assets: 13,432,500,000 United States dollar, claim clm_883D81B67C94 · ended · superseded by clm_AEC6A8645EE2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 2,488,652,000 United States dollar
Vertex Pharmaceuticals revenue: 2,488,652,000 United States dollar, claim clm_88AABB0F5900 · ended · superseded by clm_9652C550528A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 17,580,400,000 United States dollar
Vertex Pharmaceuticals total equity: 17,580,400,000 United States dollar, claim clm_89548106AA99 · ended · superseded by clm_3F0C247C527A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -199,588,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -199,588,000 United States dollar, claim clm_8982B813454B · ended · superseded by clm_EF4EBE9A383C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 3,076,400,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 3,076,400,000 United States dollar, claim clm_8AB184162D82 · ended · superseded by clm_78B1FE0A2ECC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 336,006,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 336,006,000 United States dollar, claim clm_8B3F25617388 · ended · superseded by clm_7FF4DCB7FD4C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 493,497,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 493,497,000 United States…, claim clm_8C6FF5B4800E · ended · superseded by clm_E4E066FF8D42 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 19,064,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 19,064,000 United States dollar, claim clm_8CAD8C9EBAFE · ended · superseded by clm_FCBA634A768D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 238,081,533 shares
Vertex Pharmaceuticals shares outstanding: 238,081,533 shares, claim clm_8D7D5AA15F63 · ended · superseded by clm_479F66F00F16 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 3,109,322,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 3,109,322,000 United States dollar, claim clm_8D8808029B98 · ended · superseded by clm_AC9CCBAF0908 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 784,535,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 784,535,000 United States dollar, claim clm_8E2ABC809D39 · ended · superseded by clm_3E7B3994881E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 8,318,465,000 United States dollar
Vertex Pharmaceuticals total assets: 8,318,465,000 United States dollar, claim clm_8E39CFC66249 · ended · superseded by clm_C020ABBFE645 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,116,300,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,116,300,000 United States dollar, claim clm_8EC7750600BF · ended · superseded by clm_2C985FE30E22 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 23,979,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 23,979,000 United States dollar, claim clm_8EDF57286E75 · ended · superseded by clm_8CAD8C9EBAFE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,319,041,000 United States dollar
Vertex Pharmaceuticals total assets: 2,319,041,000 United States dollar, claim clm_8F39AD572FD3 · ended · superseded by clm_1085DB3D0A82 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -200,006,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -200,006,000 United States dollar, claim clm_8F60B25A1E7E · ended · superseded by clm_185D3E640F90 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 2,478,302,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 2,478,302,000 United States dollar, claim clm_8F818D2E2F7B · ended · superseded by clm_F36C4149DAE9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 11,020,100,000 United States dollar
Vertex Pharmaceuticals revenue: 11,020,100,000 United States dollar, claim clm_9011721F7C0D · ended · superseded by clm_B151EC07FDAE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 12,618,745,000 United States dollar
Vertex Pharmaceuticals total assets: 12,618,745,000 United States dollar, claim clm_90424EB08D26 · ended · superseded by clm_883D81B67C94 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 273,563,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 273,563,000 United States…, claim clm_90976FB1C473 · ended · superseded by clm_B48FA71C174F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 20,132,100,000 United States dollar
Vertex Pharmaceuticals total assets: 20,132,100,000 United States dollar, claim clm_91183B1230B5 · ended · superseded by clm_6D94781B6A40 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,121,360 shares
Vertex Pharmaceuticals shares outstanding: 256,121,360 shares, claim clm_9180A1508E64 · ended · superseded by clm_1AA1A71F7141 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 21,726,200,000 United States dollar
Vertex Pharmaceuticals total assets: 21,726,200,000 United States dollar, claim clm_9193F0BF1A10 · ended · superseded by clm_4295FD965DBB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 31,622,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 31,622,000 United States dollar, claim clm_91E848597DF5 · ended · superseded by clm_A2ABBC5D4946 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 420,928,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 420,928,000 United States…, claim clm_92B502813AA4 · ended · superseded by clm_8C6FF5B4800E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 578,165,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 578,165,000 United States dollar, claim clm_933F26C8B388 · ended · superseded by clm_66E56361C26E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 12,115,059,000 United States dollar
Vertex Pharmaceuticals total assets: 12,115,059,000 United States dollar, claim clm_934E3BFFB8E5 · ended · superseded by clm_E7CFB5DF9247 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -696,077,000 United States dollar
Vertex Pharmaceuticals operating income: -696,077,000 United States dollar, claim clm_9472043EC2FF · ended · superseded by clm_E814D4173C5E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 851,928,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 851,928,000 United States dollar, claim clm_94A2F9498133 · ended · superseded by clm_243DDF043D62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 531,247,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 531,247,000 United States dollar, claim clm_95893F39D81D · ended · superseded by clm_393B542CC9D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 355,663,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 355,663,000 United States dollar, claim clm_95E62B146772 · ended · superseded by clm_FAD35E124DA4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 3,047,597,000 United States dollar
Vertex Pharmaceuticals revenue: 3,047,597,000 United States dollar, claim clm_9652C550528A · ended · superseded by clm_98E5E59F6D9E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 922,147,000 United States dollar
Vertex Pharmaceuticals total equity: 922,147,000 United States dollar, claim clm_979E4CDDAA4B · ended · superseded by clm_F45B3CB0C752 · 1 source (1 primary) · conf 0.95

What the statuses mean